Compare GSK plc (GSK) vs KraneShares CSI China Internet ETF (KWEB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs KraneShares CSI China Internet ETF — how do they compare? GSK plc trades at $50.33 (market cap $102.60B), while KraneShares CSI China Internet ETF trades at $27.55. The key difference: GSK plc pays a 3.57% dividend while KraneShares CSI China Internet ETF pays none, and GSK plc is trading nearer its 52-week high, KraneShares CSI China Internet ETF nearer its low. Which is the better fit depends on your goals.
| GSK | KWEB | |
|---|---|---|
Market Cap | $102.60B | — |
Sector | Health | Sector/Thematic |
52-Week High | $61.18 | $42.94 |
52-Week Low | $38.22 | $23.63 |
Enterprise Value | $123.04B | — |
Dividend Yield | 3.57% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $50.27, down 3.62% today, with a bearish technical signal but strong fundamentals including a P/E of 16.02 and net income margin of 14.52%. Recent quarters show earnings beats, and the company announced a $2.52 billion cost-saving plan to boost its drug pipeline. Cash flow from operations remains robust at $7.74 billion for 2025.
The outlook is mixed: analyst consensus leans hold (55.18%) amid valuation concerns, but revenue growth and pipeline investments support long-term potential. Key risks include competitive pressures and regulatory uncertainty, as highlighted by recent news on vaccine policies. The stock offers a dividend yield with payments scheduled through 2026.
KWEB trades at $27.54, down 5.43% over 24 hours amid pressure on Chinese equities, with technical indicators showing a bullish moving average signal but neutral oscillators. Recent news highlights institutional buying and China's export strength, though regulatory and economic risks persist. The ETF focuses on Chinese internet and AI companies, with current sentiment mixed due to geopolitical and market volatility.
The outlook for KWEB hinges on China's economic recovery and AI sector growth, offering exposure to undervalued tech giants. Key risks include U.S.-China tensions and domestic regulatory shifts, while institutional accumulation suggests long-term confidence. Investors should weigh high growth potential against elevated geopolitical and market risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About KraneShares CSI China Internet ETF
KWEB tracks the CSI Overseas China Internet Index, providing exposure to Chinese software and services companies listed in the US and Hong Kong, including giants like Tencent, Alibaba, and Meituan.
Read more on KWEB →
